Emergent BioSolutions (EBS) EBITDA (2011 - 2026)
Emergent BioSolutions (EBS) reported EBITDA of -$18.7 million for Q3 2026, compared with $102.4 million a year earlier.
Powered by 
Analysis
Emergent BioSolutions (EBS) EBITDA (2011 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Emergent BioSolutions' EBITDA came in at -$84.2 million; for FY2025, it came in at $205.7 million.
- EBITDA has a five-year compound annual growth rate of -18.0% (FY2020 to FY2025).
- By year, EBITDA came in at $7.5 million in FY2024, -$580 million in FY2023, -$22.6 million in FY2022 and $469.3 million in FY2021 (-15.7%).
- Five-year quarterly EBITDA spans a low of -$251.1 million in Q2 2023 and a high of $317 million in Q4 2021.
- Per Business Quant data, the three quarters before Q3 2026 came in at -$99.5 million (Q2 2026), $35.8 million (Q1 2026) and -$1.8 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Emergent BioSolutions | 310.37 Mn | -370.73 Mn | 29.20 Mn | -18.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -18.70 Mn |
| Jun 30, 2026 | -99.50 Mn |
| Mar 31, 2026 | 35.80 Mn |
| Dec 31, 2025 | -1.80 Mn |
| Sep 30, 2025 | 102.40 Mn |
| Jun 30, 2025 | 27.50 Mn |
| Mar 31, 2025 | 77.60 Mn |
| Dec 31, 2024 | 18.70 Mn |
| Sep 30, 2024 | 84.20 Mn |
| Jun 30, 2024 | -170.00 Mn |
| Mar 31, 2024 | 74.60 Mn |
| Dec 31, 2023 | -8.50 Mn |
| Sep 30, 2023 | -208.40 Mn |
| Jun 30, 2023 | -251.10 Mn |
| Mar 31, 2023 | -112.00 Mn |
| Dec 31, 2022 | -18.60 Mn |
| Sep 30, 2022 | -12.00 Mn |
| Jun 30, 2022 | -30.80 Mn |
| Mar 31, 2022 | 38.80 Mn |
| Dec 31, 2021 | 317.00 Mn |
API Access
Emergent BioSolutions EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();